Press release: Pivot Park grows by over 25% with the completion of the Grizzly project
Today, contractor Dura Vermeer Bouw Zuid completes the Grizzly project after nearly 2 years of construction, delivering it to Pivot Park. The 9-story building, named after Nobel laureate Marie Curie, will house offices, laboratories, and shared facilities. With the completion of this sustainable building, Pivot Park adds 11,000 square meters to its successful campus, marking an expansion of over 25 percent.
Brigitte Drees, CEO of Pivot Park, stated, “The Curie building is fully occupied by companies that already rented space at Pivot Park but needed more. Successful start-ups and scale-ups at Pivot Park frequently transform innovations into pharmaceuticals on their way to market introduction. Space is therefore in high demand. About 350 people from 6 different companies will work in the new building starting next year.”
Sustainability at its peak
The Curie building is a gas-free and Nearly Energy Neutral Building (BENG) due to the use of fossil-free installations, LED lighting, and solar panels. Additionally, the building will receive the sustainable BREEAM certificate. Erik Meerwaldt, COO of Pivot Park, said, “BREEAM examines sustainable aspects from construction to occupancy. This includes the use of materials, light, and air. It also involves waste separation during construction, even extending to biodiversity around the building.”
Future plans
Project Grizzly was funded by the province of North Brabant and the municipality of Oss, the shareholders of Pivot Park. With the completion of Grizzly, new construction at Pivot Park is finished, but future plans are already in development. Brigitte Drees stated, “First and foremost, we are incredibly proud to have realized this project. Many different parties have worked very hard. And, of course, we are also looking ahead. The next building is on the drawing board. The focus here is on lifelong learning and an incubator for startups. Naturally, we will also build new space for companies in growth. With this set of functions, we strengthen the status of the entire campus,” said Drees.
From mid-January, the first tenants will receive their keys. The official opening of the building will take place on 19 September 2024.
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional
Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes.The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
10 years ago, Pivot Park opened its doors to the world. Thanks to your commitment, support and confidence, we have been able to grow it into the successful and innovative biopharmaceutical campus it is today.
Now it’s time to celebrate!
We are therefore delighted to invite you – along with all your fellow CEOs at Pivot Park – to a special night out featuring inspiring art, a wonderful dinner and lots of opportunities to network and exchange ideas.
Erwin Wurm | Am I a House?
For the first time, the artist shows a cross-section of his work, from Narrow Furniture to One Minute Sculptures, within the walls of a historic building. Villa Constance, a former home that today houses Museum Jan Cunen, is not only a location but also part of the conversation. Because what exactly is a house?
The development of medicines in Oss began one hundred years ago. It was then that the foundations were laid for what would become a flourishing pharmaceutical sector in the Netherlands, leading to groundbreaking discoveries such as insulin and the anti-conception pill.
Today, the entire chain is still represented in Oss, from early-stage research to the commercial scale production of medicines. Working in Oss, we focus on the health of people all over the world. Employees at dozens of companies large and small put their heart and soul into new medicines, products and services that will improve lives worldwide. Together, our strength lies in our combination of broad knowledge about the development of medicines and a thorough understanding of the requirements of high-quality production.
This shared past and common values stimulate strong bonds among everyone who works in pharmaceuticals in Oss. We build on qualities, expertise and networks that go back decades. And with a wide variety of pharmaceutical companies, suppliers and scientific institutions all located nearby, we offer an attractive business climate and an excellent basis for international collaboration.
We are proud to work together to create a better and healthier future for all, a collaboration that in turn fuels growing employment: today, most pharmaceutical jobs in the Netherlands are in Oss. Here we connect talent and companies and stimulate entrepreneurship, while our expert employees are our most important asset. Their drive ensures that Oss has an influence on health all over the world.
Pharma in Oss offers endless opportunities to startups and talent in a city and region that is a joy to live and work in. We are committed to collaboration and sustainable and successful entrepreneurship. Oss’s pharmaceutical companies are intrinsically competitive while also being committed to quality and safety. This, plus their focus on new health solutions and contemporary technology, makes us a leader in our pursuit of a better life for people worldwide.
